Investing

Xencor : XNCR

XNCR

Stock Data

$12.69

$0.76 (6.37%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Xencor Inc is a pioneering biopharmaceutical company based in Pasadena, California, dedicated to developing innovative antibody and cytokine therapeutics for cancer and autoimmune diseases. With a robust pipeline, Xencor has introduced treatments like Sotrovimab for COVID-19 and Ultomiris for blood disorders. The company is also advancing research in promising areas such as bispecific antibodies and treatments for solid tumors and autoimmune conditions. Through strategic partnerships, Xencor continues to push the boundaries of medicine to improve patient care.